Variant abundance estimation for SARS-CoV-2 in wastewater using RNA-Seq quantification
View ORCID ProfileJasmijn A. Baaijens, View ORCID ProfileAlessandro Zulli, View ORCID ProfileIsabel M. Ott, View ORCID ProfileMary E. Petrone, View ORCID ProfileTara Alpert, View ORCID ProfileJoseph R. Fauver, View ORCID ProfileChaney C. Kalinich, View ORCID ProfileChantal B.F. Vogels, View ORCID ProfileMallery I. Breban, View ORCID ProfileClaire Duvallet, Kyle McElroy, Newsha Ghaeli, View ORCID ProfileMaxim Imakaev, Malaika Mckenzie-Bennett, View ORCID ProfileKeith Robison, View ORCID ProfileAlex Plocik, Rebecca Schilling, Martha Pierson, Rebecca Littlefield, Michelle Spencer, View ORCID ProfileBirgitte B. Simen, Yale SARS-CoV-2 Genomic Surveillance Initiative, View ORCID ProfileWilliam P. Hanage, View ORCID ProfileNathan D. Grubaugh, View ORCID ProfileJordan Peccia, View ORCID ProfileMichael Baym
doi: https://doi.org/10.1101/2021.08.31.21262938
Jasmijn A. Baaijens
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
Alessandro Zulli
2Department of Chemical and Environmental Engineering, Yale University, New Haven, CT, USA
Isabel M. Ott
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Mary E. Petrone
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Tara Alpert
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Joseph R. Fauver
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Chaney C. Kalinich
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Chantal B.F. Vogels
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Mallery I. Breban
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
Claire Duvallet
4Biobot Analytics, Inc., Cambridge, MA, USA
Kyle McElroy
4Biobot Analytics, Inc., Cambridge, MA, USA
Newsha Ghaeli
4Biobot Analytics, Inc., Cambridge, MA, USA
Maxim Imakaev
4Biobot Analytics, Inc., Cambridge, MA, USA
Malaika Mckenzie-Bennett
5Ginkgo Bioworks, Inc., Boston, MA, USA
Keith Robison
5Ginkgo Bioworks, Inc., Boston, MA, USA
Alex Plocik
5Ginkgo Bioworks, Inc., Boston, MA, USA
Rebecca Schilling
5Ginkgo Bioworks, Inc., Boston, MA, USA
Martha Pierson
5Ginkgo Bioworks, Inc., Boston, MA, USA
Rebecca Littlefield
5Ginkgo Bioworks, Inc., Boston, MA, USA
Michelle Spencer
5Ginkgo Bioworks, Inc., Boston, MA, USA
Birgitte B. Simen
5Ginkgo Bioworks, Inc., Boston, MA, USA
William P. Hanage
6Center for Communicable Disease Dynamics and Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Nathan D. Grubaugh
3Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
7Department of Ecology and Evolutionary Biology, Yale University, New Haven, CT, USA
Jordan Peccia
2Department of Chemical and Environmental Engineering, Yale University, New Haven, CT, USA
Michael Baym
1Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA
Data Availability
The raw SARS-CoV-2 sequencing data from New Haven wastewater (.fastq files) are available on NCBI SRA under Bioproject PRJNA741211. The clinical sequencing data can be accessed via covidtrackerct.com. The raw SARS-CoV-2 sequencing data from across the U.S. (.fastq files) are available on NCBI SRA under Bioproject PRJNA759260. The simulated wastewater sequencing data (.fastq files) for benchmarking are available on Zenodo (DOI: 10.5281/zenodo.5307070).
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA741211
Posted September 02, 2021.
Variant abundance estimation for SARS-CoV-2 in wastewater using RNA-Seq quantification
Jasmijn A. Baaijens, Alessandro Zulli, Isabel M. Ott, Mary E. Petrone, Tara Alpert, Joseph R. Fauver, Chaney C. Kalinich, Chantal B.F. Vogels, Mallery I. Breban, Claire Duvallet, Kyle McElroy, Newsha Ghaeli, Maxim Imakaev, Malaika Mckenzie-Bennett, Keith Robison, Alex Plocik, Rebecca Schilling, Martha Pierson, Rebecca Littlefield, Michelle Spencer, Birgitte B. Simen, Yale SARS-CoV-2 Genomic Surveillance Initiative, William P. Hanage, Nathan D. Grubaugh, Jordan Peccia, Michael Baym
medRxiv 2021.08.31.21262938; doi: https://doi.org/10.1101/2021.08.31.21262938
Variant abundance estimation for SARS-CoV-2 in wastewater using RNA-Seq quantification
Jasmijn A. Baaijens, Alessandro Zulli, Isabel M. Ott, Mary E. Petrone, Tara Alpert, Joseph R. Fauver, Chaney C. Kalinich, Chantal B.F. Vogels, Mallery I. Breban, Claire Duvallet, Kyle McElroy, Newsha Ghaeli, Maxim Imakaev, Malaika Mckenzie-Bennett, Keith Robison, Alex Plocik, Rebecca Schilling, Martha Pierson, Rebecca Littlefield, Michelle Spencer, Birgitte B. Simen, Yale SARS-CoV-2 Genomic Surveillance Initiative, William P. Hanage, Nathan D. Grubaugh, Jordan Peccia, Michael Baym
medRxiv 2021.08.31.21262938; doi: https://doi.org/10.1101/2021.08.31.21262938
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2853)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12560)
- Forensic Medicine (10)
- Gastroenterology (806)
- Genetic and Genomic Medicine (4434)
- Geriatric Medicine (401)
- Health Economics (716)
- Health Informatics (2850)
- Health Policy (1048)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (462)
- Neurology (4194)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6782)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (201)
- Urology (174)